NIR‐I/II‐Responsive Niosomes Co‐Encapsulating Plasmonic Gold Nanorods and IR1061 for Phototherapeutic Ablation of Cancer Cells
ChemBioChem · 14.04.2026 · 27 (7)
DOI: 10.1002/cbic.202500977 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 30.03.2026. Verfasst von Rishabh Kumar Srivastava und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Karwar, India. Hauptthemen laut MEDLINE: Gold, Nanotubes, Liposomes, Antineoplastic Agents. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India, Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Government of India.
Abstract (Originalsprache)
Near‐infrared (NIR) light‐responsive nanomaterials have emerged as powerful tools for cancer therapy, yet stable and biocompatible delivery of NIR‐II agents remains a major challenge. In this work, we develop NIR‐I/II‐responsive niosomes co‐encapsulating plasmonic gold nanorods (GNRs) and the NIR‐II dye, IR1061, forming a multifunctional nanoplatform for effective phototherapeutic ablation of cancer cells. The niosomal system provides robust encapsulation, improved dispersion stability, and biocompatibility for both photoactive components. Upon NIR‐I/II laser irradiation, the nanoplatform exhibits strong photothermal heating and substantial reactive oxygen species generation due to the synergistic integration of plasmonic GNRs and dye‐mediated effects. In vitro evaluations demonstrate efficient cellular uptake, potent photoinduced cytotoxicity, and minimal dark toxicity. The integration of photothermal and photodynamic mechanisms results in markedly enhanced therapeutic efficacy compared with individual agents. This study highlights the potential of niosomes as versatile and efficient nanocarriers for dual NIR‐window phototherapy, offering a promising route for precise and minimally invasive cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Karwar, India.
- Department of Biological Sciences, School of Engineering Sciences, SRM University, Amaravati, India.
- Center for Medical Technologies, Indian Institute of Technology Jodhpur, Karwar, India.
ORCID-Profile: Raviraj Vankayala
Förderung
- Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India
- Department of Science and Technology, Ministry of Science and Technology, India
- Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Government of India
- Department of Science and Technology, Government of India
Zitieren
APA
Srivastava, R. K., Singh, S. K., Vincy, A., Korupalli, C., & Vankayala, R. (2026). NIR‐I/II‐Responsive Niosomes Co‐Encapsulating Plasmonic Gold Nanorods and IR1061 for Phototherapeutic Ablation of Cancer Cells. ChemBioChem, 27(7). https://doi.org/10.1002/cbic.202500977
Vancouver
Srivastava RK, Singh SK, Vincy A, Korupalli C, Vankayala R. NIR‐I/II‐Responsive Niosomes Co‐Encapsulating Plasmonic Gold Nanorods and IR1061 for Phototherapeutic Ablation of Cancer Cells. ChemBioChem. 2026;27(7). doi:10.1002/cbic.202500977
BibTeX
@article{Srivastava2026,
author = {Srivastava, Rishabh Kumar and Singh, Shubham Kumar and Vincy, Antony and Korupalli, Chiranjeevi and Vankayala, Raviraj},
title = {NIR‐I/II‐Responsive Niosomes Co‐Encapsulating Plasmonic Gold Nanorods and IR1061 for Phototherapeutic Ablation of Cancer Cells},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {7},
doi = {10.1002/cbic.202500977}
}
EUVIMED